Ligand Pharmaceuticals - Following Engagement With FDA, Co Expects to Submit an Snda for Potential Modification to Liver-Monitoring Rems
Ligand Pharmaceuticals - 在與FDA的交流後,公司預計將提交一份關於潛在修改肝臟監測REMS的SNDA
Ligand Pharmaceuticals - Following Engagement With FDA, Co Expects to Submit an Snda for Potential Modification to Liver-Monitoring Rems
Ligand Pharmaceuticals - 在與FDA的交流後,公司預計將提交一份關於潛在修改肝臟監測REMS的SNDA
譯文內容由第三人軟體翻譯。